ARCHIVES

Dole to Press HCFA On Community DRG Exemptions, Calls For Meeting TO Assess Problems

This article is from The Cancer Letter archive.

Vol. 10 No. 11 | March 16, 1984

Download PDF Visit The Full Archive

Related Articles

An Earmark In The Making? NCI Urged to Boost Gastric Cancer Funding

December 17, 2013

MGI Pharma’s Irofulven In Phase III Trial Vs. 5-FU For Advanced Pancreatic Cancer.

March 2, 2001

Two founding cancer center directors step down: Harold Moses at Vanderbilt-Ingram and Charles Coltman at CTRC.

November 19, 2004

Pancreatic Cancer Research To Increase, Institute Says.

November 16, 2001

IND-Exempt Trials May Need Special Review, HCFA Says.

September 29, 2000

Study Finds No Link Between Tumor Grade and Relapse Risk

February 25, 2011